Cardiac Arrhythmias and Pharmacotherapy

Cardiac arrhythmias, ranging from atrial fibrillation to ventricular tachycardia, present significant challenges in cardiovascular care. This session will focus on the pharmacological management of arrhythmias, examining current and emerging therapies. Key topics include the use of antiarrhythmic agents such as sodium channel blockers, beta-blockers, and potassium channel modulators, along with novel biologic and gene-based treatments. Advances in personalized medicine are helping tailor drug therapies to individual arrhythmia profiles, improving patient outcomes. Additionally, the session will explore the role of electrophysiology in guiding pharmacotherapy and the latest research into arrhythmia mechanisms, offering new insights into therapeutic strategies.

 

    Related Conference of Cardiac Arrhythmias and Pharmacotherapy

    May 05-06, 2025

    19th World Drug Delivery Summit

    Vancouver, Canada
    June 16-17, 2025

    3rd Global Online Summit on Nanoscience and Nanotechnology

    Zurich, Switzerland
    June 23-24, 2025

    38th World Congress on Pharmacology

    Paris, France
    August 18-19, 2025

    40th World Congress on Pharmacology and Therapeutics

    Valencia, Spain
    September 22-23, 2025

    Pharma Biotech Expo

    Toronto, Canada
    September 23-24, 2025

    10th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    November 20-21, 2025

    21st Annual Congress on Pharmacology and Toxicology

    Aix-en-Provence, France
    November 27-28, 2025

    4th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 27-28, 2025

    13th International Conference on Clinical Trials

    Amsterdam, Netherlands
    November 27-28, 2025

    4th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland

    Cardiac Arrhythmias and Pharmacotherapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in